General Medicine and Other Clinical Trials

General Medicine

Trial Name	Description	Primary Investigator	Study Details
GS-US-685-6819 RSV	Study to evaluate the efficacy of ODV in reducing the duration of symptoms and to evaluate the safety and tolerability of study drug obeldesivir (ODV; GS-5245) in nonhospitalized adult participants with acute respiratory syncytial virus (RSV) infection. Phase 2 Randomized, Placebo-controlled Study. Sponsor Gilead Sciences	John Carardi, MD	Learn More

Trial Name	Description	Primary Investigator	Study Details
INHANCE	Trial to evaluate the safety and effectiveness of the INHANCE Stemless Reverse shoulder with Reverse Total Shoulder Arthroplasty indicated. The subjects will be randomized to either the Control – INHANCE Stemmed Reverse Total Shoulder or the STUDY – INHANCE Stemless Reverse Total Shoulder group. 2:1 Randomized, Controlled, Multi-Center, Prospective, Pre-Market. Sponsor: DePuy Synthes Products	Paul Favorito, MD	Learn More

Trial Name	Description	Primary Investigator	Study Details
Caldera Medical 522	This study will evaluate whether the Desara One single incision sling is noninferior to the midurethral Desara Blue TOR implanted via the transobturator approach (outside-in/inside-out) for the treatment of female stress urinary incontinence.The Desara One SIS and Desara Blue TOR are both Class II synthetic surgical mesh products. Non randomized post market study evaluating parallel cohorts. Surgeon determines whether to use the Desara One SIS or the Desara Blue.Sponsor is Caldera Medical.	Mickey Karram, MD	Learn More